- News & Events
- Contact Us
Amgen Announces Award for Science Teaching Excellence in CaliforniaFOR IMMEDIATE RELEASE
THOUSAND OAKS, Calif. - January 24, 2003 - Amgen (Nasdaq: AMGN) announced today the 2003 Amgen Award for Science Teaching Excellence in California, its statewide recognition program for science education. Five K-12 educators who work in either public or private schools in California will each receive an unrestricted $10,000 award from Amgen, and statewide recognition, at a special award ceremony in Los Angeles in May.
Amgen developed the Amgen Award for Teacher Excellence in Ventura County 11 years ago. Last year, the company broadened the award program to include teachers throughout the state, and focused solely on those who teach science. Amgen also conducts similar programs in Colorado; Louisville, Kentucky; Puerto Rico; Rhode Island, and Seattle, Washington.
Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level the science teacher teaches; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award, including the teacher's attributes in the areas of creativity, effectiveness, best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen Award for Science Teaching Excellence, Amgen Inc., One Amgen Center Drive, Mailstop 38-3-B, Thousand Oaks, CA 91320-1799. Nominations can also be submitted electronically, at www.Amgen.com/corporate/AmgenTeacher/index.html. Nominations for the award will be accepted immediately, through February 28, 2003.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
Barbara Bronson Gray: 805/447-4949
Amgen, Corporate Communications
EDITOR'S NOTES: An electronic version of this news release may be accessed via our web site at http://www.amgen.com.